ArticleAnnals of hematology2026
Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screening.
Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: Thalassemia is an inherited autosomal recessive hematologic disorder characterized by chronic hemolytic anemia due to impaired synthesis of globin chains. A three-level prevention system has effectively reduced the birth rate of affected children and enabled early intervention in Guangxi, China. However, conventional blood tests lack accuracy, and hemoglobin electrophoresis has low predictive value for α-thalassemia with low HbA₂. While genetic testing remains the gold standard, its high-cost limits large-scale use. Thus, a fast, low-cost, and reliable screening method is urgently needed for effective thalassemia control. Methods:An AI-driven detection system for intelligent recognition and quantitative analysis of erythrocyte morphology was developed using a large-scale dataset. This system was applied to both thalassemia and control samples to identify erythrocytes. The eXtreme Gradient Boosting (XGB) and logistic regression (LR) models were developed to distinguish thalassemia cases from controls, classify thalassemia subtypes, and differentiate thalassemia from iron deficiency anemia (IDA) based on the morphological features of red blood cell (RBC) identified by the system. Results: The XGB and LR models achieved AUROC values of 0.92 and 0.98, respectively, for distinguishing thalassemia cases from controls. Subclass analysis showed that the XGB model reached an AUROC of 0.99 for α-thalassemia and 0.98 for β-thalassemia, while the LR model achieved an AUROC of 0.95 for α-thalassemia and 0.99 for β-thalassemia. The LR model outperformed the XGB model (AUROC 0.88 vs. 0.75) in differentiating IDA from thalassemia. Conclusions: Both the XGB and LR models demonstrate high accuracy in predicting thalassemia and distinguishing its subtypes, based on using RBC morphological features extracted by an AI-driven detection system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.